Business Wire

QpiAI Announces Dawn of Quantum Era in India With 25 Qubit Quantum Computer

Share

QpiAI, a leader in quantum computing and generative AI, announced its First Quantum computer launch code named QpiAIIndusQuantum Computer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250415961497/en/

QpiAI Gen-1 25 qubit Quantum computer Indus, picture from QpiAI Bangalore centre with CEO Dr Nagendra Nagaraja (Left) and VP of Quantum hardware Dr Manjunath R V (Right).

Dr Nagendra Nagaraja, CEO and Founder of QpiAI, said, "We are excited about our roadmap to commercialize quantum computers, leveraging large-scale qubit integration and logical qubits. The T1 and T2 times for our current 25-Qubit Indus Quantum Computer are 30 μs and 25 μs, respectively, characterized by our in-house developed quantum control electronics cluster, and are expected to increase to 100 μs soon. Furthermore, with our patented qubit architecture, we expect to reach a T1 time of 1 ms in early 2026. With single-qubit gate fidelity of 99.7% and two-qubit gate fidelity of 96%, supporting all native gate sets, our system is interfaced with QpiAI quantum software SDKs for application development. We will soon be expanding to 64-qubit quantum computers. We will have rich partnerships with fellow component suppliers, large pharma and chemical companies, data center players, and hyperscalers to commercialize quantum computing. Our key IP lies in using an AI-based agentic system to manufacture qubits and fine-tune them to obtain desired fidelity, error correction, and noise levels, where the Agentic AI system in our datacenter works in a closed loop with the quantum computer."

Department of Science and Technology (DST) who is also shareholder of QpiAI via NQM (National Quantum Mission) announced QpiAI Indus Quantum computer in a LinkedIn post

https://www.linkedin.com/posts/indiadst_worldquantumday-nqm-activity-7317554620015288320-jYgH?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAEhG18BESsICj9lOj3oH7lnWocQr9DW9Lk

QpiAI Quantum and AI Full-Stack Vertical Integration

QpiAI has developed full-stack quantum computing technology vertically integrating AI and Quantum computing systems combining AI, quantum computers, algorithms, software, and applications. The Gen-1 QpiAI system is built with efficient Quantum-HPC integration with a colocated HPC datacenter for high-throughput and low-latency computing. The QpiAI quantum applications stack combines AI-driven quantum compilation with application-specific architectures for maximizing hybrid quantum-classical performance. QpiAI Quantum software platforms and products, including QpiAI-Logistics, QpiAI-Opt, QpiAI-ML, QpiAI-Pharma, and QpiAI-Matter, are targeted for core quantum applications in logistics, finance, material discovery, and pharma industries.

QpiAI Quantum QPU Technology

QpiAI quantum computers use superconducting qubits and roadmap to experiment with CMOS-based spin qubits in future models. The current generation of qubits is based on various architectures of superconducting qubits design. QpiAI NISQ (Noisy Intermediate-Scale Quantum) qubits and QpiAI FTQC (Fault-tolerant Quantum Computing) qubits are based on QpiAI proprietary qubit architecture named QpiAI Qubits. Transmon qubits are stabilized and error-corrected based on the surface codes with various distances. For higher reliability in fault-tolerant computing, QpiAI FTQC Qubits are error-corrected using Q-LDPC codes with new architectures invented by QpiAI to ensure high performance and low error rates.

Quantum computing today faces limited scalability and reliability challenges due to errors from decoherence, noise, and gate inaccuracies, impacting readiness for industrial applications. To address these, QpiAI is advancing error mitigation on NISQ devices with built-in Surface code schemes, and implementing Q-LDPC codes within our fault-tolerant roadmap. We aim to create scalable, reliable quantum systems capable of supporting complex, high-impact applications.

AI Technology

QpiAI has built advanced next generation generative AI and agentic AI systems that can autonomously navigate complex scenarios and build emergent intelligence through agent-based modeling. Our optimized data-to-intelligence stack and high-performance infrastructure enables modeling and automation at unprecedented scales, while ensuring a seamless transition to quantum-based modeling in the future with the optimal combination of bits, qubits, and neurons.

About QpiAI

QpiAI (https://www.qpiai.tech) is a Bangalore based deep-tech startup pioneering the convergence of Artificial Intelligence and Quantum Computing to solve some of the world’s most complex industrial and scientific challenges. QpiAI’s vertically integrated stack enables seamless innovation across hardware, software, and applications. The portfolio includes QpiAI-Explorer, an education platform; QpiAI-Quantum, offering SDKs, compilers, and simulators for quantum development; QpiAI-Opt, a powerful optimization engine for scientific and industrial use cases; QpiAI-Logistics, for route planning and supply chain optimization; QpiAI-Pharma, designed for drug discovery and protein-ligand modeling; QpiAI-Pro, a generative AI development suite; and QpiAI Agent-Hive, enabling intelligent agentic AI workflows.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250415961497/en/

Contacts

Contact email: info@qpiai.tech

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000 ® Index28.6.2025 02:30:00 EEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 23:44:00 EEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 17:00:00 EEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 15:00:00 EEST | Press release

To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this manual process demands significant time and effort and can lead to inconsistent results,” said Dr. A

Pure Lithium Founder & CEO Emilie Bodoin Recognized for Trailblazing Woman of the Year at 2025 Volta Foundation Awards at 17 th Annual Fastmarkets Lithium Supply and Battery Raw Materials Conference27.6.2025 13:00:00 EEST | Press release

Pure Lithium Corporation, a disruptive vertically integrated lithium metal battery technology company, is pleased to announce that its Founder, Chairman & CEO, Emilie Bodoin received special recognition for Trailblazing Woman of the Year Award Sponsored by ExxonMobil at the 2025 Fastmarkets Volta Awards Ceremony, in Las Vegas, Nevada on June 24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627170164/en/ This award celebrates an exceptional female leader who has demonstrated outstanding leadership, vision, and impact within her industry. It recognizes achievements in driving innovation, fostering diversity, and inspiring others while making significant contributions to her organization. “I am truly honored to receive special recognition for this award. One of the best things about my role is the opportunity to lead by example and encourage and inspire women and girls who may not yet recognize their potential. To all of m

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye